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Autophagy and apoptotic genes implicated in Alzheimer’s disease are modulated 
following infection of neuronal cells with Chlamydia pneumoniae
Denah Appelt, Ian Kohler, Annette Slutter, Juliana Zoga, Susan Hingley, Brian Balin
Philadelphia College of Osteopathic Medicine, Center for Chronic Disorders of Aging, Philadelphia, PA, USA
Background: The focus of the current studies was to determine the relationship between the molecular
mechanisms interconnecting autophagy and apoptosis following Chlamydia pneumoniae infection in
neuronal cells. Dysfunctions in apoptosis and autophagy have been implicated in the neurodegenera-
tion associated with Alzheimer’s disease (AD). Autophagy in AD pathogenesis has been shown to play
a role in amyloid processing through the endosomal-lysosomal system. Apoptosis may contribute to the
neuronal cell loss observed in AD; however, there is limited evidence of the apoptotic process proceed-
ing to terminal completion. Although Aβ1-42 has been shown to induce apoptosis in neurons and may
be an early factor in AD, our previous investigations demonstrated that neurons infected with 
Chlamydia pneumoniae are resistant to apoptosis, and that Aβ1-42 is induced following this infection.
Thus, these studies address infection as an initiator/trigger or inhibitor for the processes of autophagy
and apoptosis observed in Alzheimer’s disease.  
Methods: SKNMC neuronal cells obtained from ATCC were infected with the AR39 strain of
Chlamydia pneumoniae at an MOI=1 for 24, 48, and 72hrs and were analyzed using Real-time PCR 
arrays from SABiosciences specific for autophagy and apoptosis genetic markers. 
Results: Some major genes associated with apoptosis such as BID, DAPK1, TP53, TP73 were down
regulated by 72hrs post-infection. Genes associated with the regulation of autophagic vacuole forma-
tion such as ATG3, ATG4B, ATG4C, ATG9A, ATG9B, ATG12, IRGM, and BECN1 were up-regu-
lated within 72hrs post-infection. With regards to genes involved with co-regulation of autophagy and
apoptosis, BNIP3 was significantly up-regulated within 48-72hrs post-infection. Of the genes linking
autophagosomes to lysosomes, FAM176A was up-regulated throughout 24-72hrs post-infection. 
Conclusions: Modulation of autophagy and apoptosis genes occurs in neuronal cells at 24, 48, and
72hrs post- infection with Chlamydia pneumoniae.  These genetic changes lead to dysfunction in these
basic cellular processes; dysfunction in these processes has been shown to contribute to the 
neuropathology of late-onset Alzheimer’s disease. This work will allow future studies to further focus
on the apoptotic and autophagic pathways to better understand how a pathogen such as Chlamydia
pneumoniae plays a role in the development of late-onset Alzheimer’s disease.
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Neurodegeneration has been well documented in the CNS of Alzheimer individuals and a continuum
of abnormalities has been identified within the AD brain.  Strong evidence suggests that abnormalities
of the autophagy and apoptosis pathways are contributing factors in the pathogenesis of Alzheimer’s
disease. Our laboratory has focused on studying the role of infection with C. pneumoniae as a causative
agent in late onset AD. In separate studies, polymerase chain reaction detected C. pneumoniae DNA in
80 to 90% of postmortem sporadic AD brain samples [1,2], but only 5-11% of postmortem brain
samples from age-matched, non-AD, control individuals. Furthermore, a murine model has been 
developed in which mice infected with C. pneumoniae demonstrate deposits of amyloid in brain areas
typically affected in AD [3].
Recently, we have demonstrated that C. pneumoniae is capable of inhibiting apoptosis in neuronal cells
thereby prolonging the viability of the infected neuronal cell [4]. Other laboratories have demonstrated
that chlamydiae-infected host cells were resistant to proapoptotic stimuli such as TNFα, Fas antibody,
staurosporine, and UV-light [5]. C. pneumoniae infection has also been shown to modulate pro-apoptotic
cytoplasmic proteins, such as caspase-3 and cytochrome c, as well as the anti-apoptotic mitochondrial
protein Bcl-2 and the anti-apoptotic nuclear protein NF-κB[6]. 
In some instances, cells may activate the autophagy pathway instead of, or before, initiating apoptosis. 
Induction of the autophagic process may lead to modulation of the apoptotic process. Autophagy is 
associated with the endosomal-lysosomal system, in which contents of an autophagosome are degraded as
a result of the autophagosome fusing with the lysosome[7,8]. An increase in the number of autophagic
vacuoles (AVs) was identified in neurons from AD brains implicating autophagy as a pathological process
in AD [9]. The endosomal pathway is linked to the lysomal system because early endosomes fuse with late
endosomes or lysosomes.  Neurons from AD brains have been found to exhibit enlarged early endosomes.
This is significant in AD because early endosomes take in proteins such as apolipoprotein E and APP, and
it has been determined that Aβ is formed in early endosomes [10].
Typically, autophagy and apoptosis are common pathways by which infected cells attempt to rid them-
selves of the infectious agent and cells incapable of eliminating the infectious agent, undergo cell death.
Intriguingly, these pathways appear to be altered in C. pneumoniae infected neuronal cells. These studies
are an attempt to identify the defects in the regulation of genes associated with apoptosis and 
autophagy in neuronal cells as observed in AD following an infection by C. pneumoniae
The SKNMC (ATCC) human neuroblastoma cell line were infected with ATCC’s AR39 strain of 
Chlamydia pneumoniae at an MOI = 1 for 24, 48, and 72 hrs.   Cells were immunolabled with
FITC- chlamydia antibody 61C75 (Fitzgerald) for verification of infection.   The Human Autophagy
RT² Profiler™ PCR Array from SAbiosciences was used to analyze the expression of a panel of genes
involved in autophagy and apoptosis.   All data was derived from experiments performed in triplicate.
RT-PCR of SKNMC neuronal cells infected with C. pneumoniae for 24, 48, and 72hrs
Varification of C. pneumoniae infection for 24, 48, and 72hrs by immunocytochemistry. 





Function Gene Symbol Gene Name
Autophagy Machinery Components
•Autophagic Vacuole Formation
AMBRA1 Autophagy/beclin-1 regulator 1
ATG4A ATG4 autophagy related 4 homolog A (S. cerevisiae)
ATG4C ATG4 autophagy related 4 homolog C (S. cerevisiae)
ATG9A ATG9 autophagy related 9 homolog A (S. cerevisiae)
BECN1 Beclin 1, autophagy related
MAP1LC3B Microtubule-associated protein 1 light chain 3 beta
ATG4D ATG4 autophagy related 4 homolog D (S. cerevisiae)
•Genes Linking Autophagosome to 
Lysosome
DRAM Damage-regulated autophagy modulator
FAM176A Family with sequence similarity 176, member A
• Protein Transport
ATG10 ATG10 autophagy related 10 homolog (S. cerevisiae)
ATG16L1 ATG16 autophagy related 16-like 1 (S. cerevisiae)
RAB24 RAB24, member RAS oncogene family
Co-Regulators of Autophagy and Apoptosis
BAK1 BCL2-antagonist/killer 1
BNIP3 BCL2/adenovirus E1B 19kDa interacting protein 3
CASP3 Caspase 3, apoptosis-related cysteine peptidase
FAS Fas (TNF receptor superfamily, member 6)
NFKB1 Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells 1
Autophagy Induction by Intracellular  
Pathogens
IFNA2 Interferon, alpha 2
IFNA4 Interferon, alpha 4
IFNG Interferon, gamma
Autophagy in Response to Other 
Intracellular Signals
ARSA Arylsulfatase A
EIF4G1 Eukaryotic translation initiation factor 4 gamma, 1
ESR1 Estrogen receptor 1
PIK3C3 Phosphoinositide-3-kinase, class 3
PIK3R4 Phosphoinositide-3-kinase, regulatory subunit 4
PRKAA2 Protein kinase, AMP-activated, alpha 2 catalytic 
subunit
TMEM74 Transmembrane protein 74
TMEM77 Transmembrane protein 77
ULK2 Unc-51-like kinase 2 (C. elegans)
UVRAG UV radiation resistance associated gene
 
        
Modulation of genes associated with the autophagy and apoptosis pathways is observed in neuronal cells
after 24, 48, and 72hrs of infection with C. pneumoniae. These genetic changes lead to dysfunction in the
basic cellular processes of autophagy and apoptosis; consequently dysfunction in these processes has been
shown to contribute to the neuropathology of late onset Alzheimer’s disease. This work will allow future
studies to further focus on the analysis of genes involved in the apoptotic and autophagic pathways at to
better understand how a pathogen such as C. pneumoniae plays a role in the development of AD.
Conclusions
This work was funded by the Center for Chronic Disorders of Aging at the
Philadelphia College of Osteopathic Medicine, the Adolph and Rose Levis 
Foundation for Alzheimer’s Disease Research, Health Research/CURE Program,
PA Department of Health and the undergraduate science education program
grant awarded to Washington and Jefferson from the Howard Hughes Medical
Institute and W&J College’s 2008 Undergraduate Science Education Program
Grant #5200632
Funding
